Content Type: Research Publications

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017

March 15, 2026

Research Ethics for Emerging Trial Designs: Does Equipoise Need to Adapt?

March 15, 2026

Tertiary Patenting on Drug-Device Combination Products in the United States

March 15, 2026

Studying New Antibiotics for Multidrug Resistant Infections: Are Today’s Patients Paying for Unproved Future Benefits?

March 15, 2026

The FDA Breakthrough-Drug Designation—Four Years of Experience

March 15, 2026

Availability of Pediatric Information In European Medicines Agency Approvals

March 15, 2026

Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health

March 15, 2026

Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety

March 15, 2026

Generic Drug Approvals Since the 1984 Hatch-Waxman Act

March 15, 2026

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States

March 15, 2026

Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage

March 15, 2026

Variations in Time of Market Exclusivity Among Top-Selling Prescription Drugs in the United States

March 15, 2026